Merck Financial Statements From 2010 to 2026

6MK Stock  EUR 103.20  0.20  0.19%   
Merck's financial statements offer valuable quarterly and annual insights to potential investors, highlighting the company's current and historical financial position, overall management performance, and changes in financial standing over time. Key fundamentals influencing Merck's valuation are provided below:
Enterprise Value Revenue
5.0114
We have found sixty-two available fundamental ratios for Merck, which can be analyzed and compared to other ratios and to its peers in the industry. All investors should make sure to check all of Merck last-minute market performance against the performance between 2010 and 2026 to make sure the company can sustain itself down the road.

Merck Total Revenue

57.09 Billion

Check Merck financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Merck's main balance sheet or income statement drivers, such as Tax Provision of 2.1 B, Interest Income of 239.5 M or Interest Expense of 1 B, as well as many indicators such as . Merck financial statements analysis is a perfect complement when working with Merck Valuation or Volatility modules.
  
This module can also supplement various Merck Technical models . Check out the analysis of Merck Correlation against competitors.

Merck Balance Sheet

Current ValueLast YearHistorical Average 10 Year Trend
Total Assets109.6 B134.7 B94.3 B
Slightly volatile
Total Current Liabilities27.3 B32.7 B24.2 B
Slightly volatile
Total Stockholder Equity38.7 B53.3 B32.4 B
Slightly volatile
Net Debt24 B27.4 B20.1 B
Slightly volatile
Retained Earnings57.9 B72.5 B49.4 B
Slightly volatile
Accounts Payable4.4 B4.7 B3.8 B
Slightly volatile
Cash10.5 B15.2 B9.2 B
Slightly volatile
Non Current Assets Total75.3 B90.1 B64.6 B
Slightly volatile
Non Currrent Assets Other12 B18.5 B9.8 B
Slightly volatile
Long Term Debt30.7 B39.6 B25 B
Slightly volatile
Net Receivables9.4 B11.8 B8.1 B
Slightly volatile
Good Will22.3 B24.9 B19.7 B
Slightly volatile
Common Stock Shares OutstandingB2.3 B2.5 B
Slightly volatile
Non Current Liabilities Total43.5 B48.7 B37.5 B
Slightly volatile
Inventory6.5 BB5.8 B
Slightly volatile
Other Current AssetsB10 B5.7 B
Slightly volatile
Total Liabilities70.8 B81.3 B61.7 B
Slightly volatile
Net Invested Capital73.1 B95.9 B61.7 B
Slightly volatile
Long Term Investments395.9 M416.7 M3.6 B
Slightly volatile
Short and Long Term Debt2.7 B2.4 B4.2 B
Slightly volatile
Total Current Assets34.3 B44.6 B29.6 B
Slightly volatile
Capital Stock1.4 B1.6 B1.8 B
Slightly volatile
Non Current Liabilities Other7.9 B5.8 B10.6 B
Slightly volatile
Net Working Capital6.9 B11.9 B5.4 B
Slightly volatile
Intangible Assets18.4 B18.8 B14.5 B
Slightly volatile
Property Plant And Equipment Net21.9 B27.3 B17.9 B
Slightly volatile
Property Plant And Equipment Gross42 B49.4 B36.2 B
Slightly volatile
Other Current Liabilities868.8 M977.4 M1.1 B
Slightly volatile

Merck Income Statement

Current ValueLast YearHistorical Average 10 Year Trend
Tax Provision2.1 B3.2 B2.3 B
Pretty Stable
Interest Income239.5 M477.2 M293.2 M
Pretty Stable
Interest ExpenseB1.5 B902.6 M
Slightly volatile
Selling General Administrative11.1 B12.4 B10.3 B
Slightly volatile
Total Revenue57.1 B73.8 B49 B
Slightly volatile
Gross Profit40.8 B56.3 B34.5 B
Slightly volatile
Operating Income12.8 B23.3 B11.1 B
Slightly volatile
Net Income From Continuing Ops10.3 B19.7 B8.5 B
Slightly volatile
Research Development16.9 B20.6 B13.1 B
Slightly volatile
EBITDA9.3 B7.6 B11.6 B
Slightly volatile
Cost Of Revenue16.3 B17.5 B14.4 B
Slightly volatile
Total Operating Expenses44.2 B50.5 B37.8 B
Slightly volatile
Reconciled Depreciation4.3 B5.2 B4.3 B
Pretty Stable
Income Before Tax12.4 B22.9 B10.8 B
Slightly volatile
Net Income10.8 B19.7 B8.8 B
Slightly volatile
EBIT17.3 B21 B14.8 B
Slightly volatile

Merck Cash Flow Statement

Current ValueLast YearHistorical Average 10 Year Trend
Free Cash Flow11.8 B20.8 B10.2 B
Slightly volatile
Begin Period Cash Flow9.2 B7.9 B7.3 B
Slightly volatile
Depreciation4.3 B5.2 B4.3 B
Pretty Stable
Other Non Cash Items4.1 B4.6 B2.8 B
Slightly volatile
Capital Expenditures4.2 B3.9 B3.3 B
Slightly volatile
Total Cash From Operating Activities16 B24.7 B13.5 B
Slightly volatile
Net Income10.8 B19.7 B8.8 B
Slightly volatile
End Period Cash Flow10.8 B15.3 B9.3 B
Slightly volatile
Stock Based Compensation606.6 M875.1 M515.8 M
Slightly volatile

Merck Fundamental Market Drivers

About Merck Financial Statements

Merck stakeholders use historical fundamental indicators, such as Merck's revenue or net income, to determine how well the company is positioned to perform in the future. Although Merck investors may analyze each financial statement separately, they are all interrelated. For example, changes in Merck's assets and liabilities are reflected in the revenues and expenses on Merck's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Merck Co. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Total Revenue73.8 B57.1 B
Cost Of Revenue17.5 B16.3 B

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Other Information on Investing in Merck Stock

Merck financial ratios help investors to determine whether Merck Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Merck with respect to the benefits of owning Merck security.